Disclosed positions

Estimated from their latest filings — positions may have changed since

$27.96M

combined est. value

Stock	Shares	Price	Value	Weight	As of
KYMRKymera Therapeutics, Inc.	244,883	$114.16	$27.96M	100%	2026-06-30

KYMR

Kymera Therapeutics, Inc.

$27.96M

244,883 sh

All filings on record

Every Form 4 transaction we track for this filer

all 13buys 0sells 9

Stock	Transaction	Date	~6mo later
KYMRKymera Therapeutics, Inc.	Sell $376.6K · 3,200 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $719.9K · 6,153 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $923.2K · 7,971 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $5.90M · 51,375 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $469.3K · 4,110 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $124.1K · 1,100 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $189.7K · 1,700 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Sell $165.8K · 1,500 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Exercise $327.1K · 61,378 sh	2026-06-30	—
KYMRKymera Therapeutics, Inc.	Exercise $26.3K · 12,653 sh	2026-06-02	—
KYMRKymera Therapeutics, Inc.	Exercise $31.2K · 15,000 sh	2026-05-18	—
KYMRKymera Therapeutics, Inc.	Sell $3.96M · 79,220 sh	2025-09-17	—
KYMRKymera Therapeutics, Inc.	Exercise $164.8K · 79,220 sh	2025-09-17	—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$376.6K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$719.9K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$923.2K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$5.90M

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$469.3K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$124.1K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$189.7K

—

KYMRSell

2026-06-30 · Kymera Therapeutics, Inc.

$165.8K

—

KYMRExercise

2026-06-30 · Kymera Therapeutics, Inc.

$327.1K

—

KYMRExercise

2026-06-02 · Kymera Therapeutics, Inc.

$26.3K

—

KYMRExercise

2026-05-18 · Kymera Therapeutics, Inc.

$31.2K

—

KYMRSell

2025-09-17 · Kymera Therapeutics, Inc.

$3.96M

—

KYMRExercise

2025-09-17 · Kymera Therapeutics, Inc.

$164.8K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.